The Chemours Company[CC] stock saw a move by -1.42% on Thursday, touching 1.6 million. Based on the recent volume, The Chemours Company stock traders appear to be active. The most recent trading volume of CC shares recorded 164.12M shares, which represents the daily volume of traded shares. Analysts estimates state that The Chemours Company [CC] stock could reach median target price of $18.00.

The Chemours Company [CC] stock additionally went up by +19.88% in the period of the 7 days, recording a gain in performance by 22.83% in the last 30 days. The yearly more of CC stock is set at -62.70% by far, with shares price recording returns by -31.19% in the latest quarter. Over the past six months, CC shares showcased -57.48% decrease. CC saw -63.47% change opposing the low price in the last 12 months, also recording 38.15% compared to high within the same period of time.

The Chemours Company [NYSE:CC]: Analyst Rating and Earnings

Its stock price has been found in the range of 11.71 to 44.28. This is compared to its latest closing price of $16.41.

Keep looking out for the next-scheduled quarterly financial results that this company is expected to put out, which is slated to occur on Thu 7 Nov (In 57 Days).

Fundamental Analysis of The Chemours Company [CC]

Now let’s turn to look at profitability: with a current Operating Margin for The Chemours Company [CC] sitting at +18.50 and its Gross Margin at +30.17, this company’s Net Margin is now 10.30%. These metrics indicate that this company is not generating as much profit, after accounting for expenses, compared to its market peers.

This company’s Return on Total Capital is 24.64, and its Return on Invested Capital has reached 19.60%. Its Return on Equity is 106.19, and its Return on Assets is 13.58. These metrics all suggest that The Chemours Company is doing well at using the money it earns to generate returns.

Turning to investigate this organization’s capital structure, The Chemours Company [CC] has generated a Total Debt to Total Equity ratio of 391.72. Similarly, its Total Debt to Total Capital is 79.66, while its Total Debt to Total Assets stands at 53.95. Looking toward the future, this publicly-traded company’s Long-Term Debt to Equity is 5.79, and its Long-Term Debt to Total Capital is 390.43.

What about valuation? This company’s Enterprise Value to EBITDA is 3.40 and its Total Debt to EBITDA Value is 2.63. The Enterprise Value to Sales for this firm is now 0.87, and its Total Debt to Enterprise Value stands at 0.50. The Chemours Company [CC] has a Price to Book Ratio of 4.75, a Price to Cash Flow Ratio of 4.52 and P/E Ratio of 4.69. These metrics all suggest that The Chemours Company is more likely to generate a positive ROI.

Shifting the focus to workforce efficiency, The Chemours Company [CC] earns $948,286 for each employee under its payroll. Similarly, this company’s Receivables Turnover is 7.46 and its Total Asset Turnover is 0.91. This publicly-traded organization’s liquidity data is also interesting: its Quick Ratio is 1.26 and its Current Ratio is 1.93. This company, considering these metrics, has a healthy ratio between its short-term liquid assets and its short-term liabilities, making it a less risky investment.

The Chemours Company [CC] has 164.12M shares outstanding, amounting to a total market cap of $2.69B. Its stock price has been found in the range of 11.71 to 44.28. At its current price, it has moved down by -63.47% from its 52-week high, and it has moved up 38.15% from its 52-week low.

This stock’s Beta value is currently 2.49, which indicates that it is 6.33% more volatile that the wider market. This stock’s Relative Strength Index (RSI) is at 59.94. This RSI score is good, suggesting this stock is neither overbought or oversold.

Conclusion: Is The Chemours Company [CC] a Reliable Buy?

Shares of The Chemours Company [CC], overall, appear to be a solid investment option, with Wall Street analysts expecting its price to rise considerably in the next 12 months. This company generates high value from the labor resources and other capital it has available, and while it has heavy Long-Term Debt to Equity, the majority of the metrics point to this investment being highly attractive.